Thirty-two infants (40聽卤聽2.3 weeks gestational age; 10.6 days at time of surgery) undergoing open-heart surgery with cardiopulmonary bypass were randomized to receive an intravenous lipid emulsion with (treatment) or without (control) eicosapentaenoic and docosahexaenoic acid in this prospective, randomized, double-blind, controlled trial.
Mean plasma TNF-伪 concentration was significantly (p聽=聽0.003) lower in the treatment (5.9聽pg/mL) compared to the control group (14.8聽pg/mL). In infants without sepsis, plasma TNF-伪 did not differ according to treatment, however when sepsis developed, mean plasma TNF-伪 was 21.1聽pg/mL and 1.5聽pg/mL (p聽=聽0.0007) in control and treatment groups, respectively. Plasma TNF-伪 was positively correlated with length of hospital stay in the control group (p聽=聽0.01), and negatively correlated with length of stay in the treatment group (p聽=聽0.004), with a significant time by treatment interaction (p聽=聽0.02).
Providing a lipid emulsion containing eicosapentaenoic and docosahexaenoic acid reduces TNF-伪 concentrations in infants undergoing open-heart surgery. Lipid emulsions containing eicosapentaenoic and docosahexaenoic acid may ameliorate the inflammatory response among critically ill infants.
This trial was registered at as NCT00336908.